Track topics on Twitter Track topics that are important to you
Stada, the German generic drugs manufacturer, saw its two most senior executive leave the company for ‘personal reasons’.
Matthias Wiedenfels, CEO, and Helmut Kraft, CFO, left the company only days after a takeover bid by Bain Capital and Cinven had failed to secure enough shareholder support.
The supervisory board of Stada announced that Angelbert Coster Tjeenk Willink, a former executive at Boehringer Ingelheim, will be the interim CEO and Bernhard Düttmann will become interim CFO.
Original Article: Stada CEO and CFO tumble in takeover turmoilNEXT ARTICLE
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...